NA
Natural Capsules Limited
NATCAPSUQ.BO · BSE
₹220.95 -2.26% (-₹5.10)
1M +44.08%
Market Cap ₹2.35B
P/E Ratio -
Div. Yield -
ROE 9.06%
Piotroski F-Score Weak
2/9Valuation
44 /100
Fair P/S 1.23x
P/B 1.06x
EV/EBITDA 2,084.33x
Growth
40 /100
Stable Rev. growth 7.80%
Book val. growth 41.07%
EPS growth 69.19%
Profitability
10 /100
Weak Net margin 11.29%
Op. margin 9.45%
FCF margin 0.00%
Quality
6 /100
Poor ROE 9.06%
ROA 5.08%
Asset turnover 0.45x
Debt
30 /100
High Current ratio 1.03x
Int. coverage -1.28x
Net debt/EBITDA 666.59x
Stability
58 /100
Moderate Rev. volatility 18.73%
EPS volatility 47.51%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NATCAPSUQ.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sunil Mundra
Employees
620
Headquarters
Bengaluru